These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11250041)

  • 21. Kidney graft failure and presensitization against HLA class I and class II antigens.
    Süsal C; Opelz G
    Transplantation; 2002 Apr; 73(8):1269-73. PubMed ID: 11981420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor-specific antibody detection: comparison of single antigen assay and Luminex crossmatches.
    Caro-Oleas JL; González-Escribano MF; Toro-Llamas S; Acevedo MJ; Martinez-Bravo MJ; Aguilera I; Núñez-Roldán A
    Tissue Antigens; 2010 Nov; 76(5):398-403. PubMed ID: 20630037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA class I epitopes: A and B loci.
    El-Awar N; Cook D; Terasaki PI
    Clin Transpl; 2006; ():79-94. PubMed ID: 18365370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hidden Patterns of Anti-HLA Class I Alloreactivity Revealed Through Machine Learning.
    Vittoraki AG; Fylaktou A; Tarassi K; Tsinaris Z; Siorenta A; Petasis GC; Gerogiannis D; Lehmann C; Carmagnat M; Doxiadis I; Iniotaki AG; Theodorou I
    Front Immunol; 2021; 12():670956. PubMed ID: 34386000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated humoral renal allograft rejection due to HLA-C14 mediated allosensitization to HLA-Bw6.
    Persaud SP; Duffy B; Phelan DL; Mohanakumar T; Delos Santos R; Gaut JP; Liu C
    Hum Immunol; 2017 Nov; 78(11-12):692-698. PubMed ID: 29024716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The correlation of HLA allele frequencies and HLA antibodies in sensitized kidney transplantation candidates.
    Fu Q; Wang C; Zeng W; Liu L
    Transplant Proc; 2012 Jan; 44(1):217-21. PubMed ID: 22310618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positive virtual crossmatch with negative flow crossmatch results in two cases.
    Jacob EK; De Goey SR; Gandhi MJ
    Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel ELISA-based crossmatch procedure to detect donor-specific anti-HLA antibodies responsible for corneal allograft rejections.
    Sel S; Schlaf G; Schurat O; Altermann WW
    J Immunol Methods; 2012 Jul; 381(1-2):23-31. PubMed ID: 22561526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and applications of new monoclonal antibodies against human lymphocyte antigen-A and -B antigens.
    Harpprecht J; Westphal E; Müller-Ruchholtz W
    Diagn Clin Immunol; 1988; 5(6):388-92. PubMed ID: 3219787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of human monoclonal antibodies for monitoring donor derived soluble HLA class I molecules in the serum of heart transplant recipients.
    Koelman CA; Mulder A; Jutte NH; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
    Hum Immunol; 1998 Feb; 59(2):106-14. PubMed ID: 9536433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to HLA class II antigens as a risk factor for acute rejection of the allogeneic kindey.
    Slavcev A; Lacha J; Sajdlova H; Vitko S; Valhova S; Striz I; Ivaskova E
    Ann Transplant; 2004; 9(3):44-7. PubMed ID: 15759547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of donor-specific anti-HLA antibodies during episodes of renal allograft rejection.
    Supon P; Constantino D; Hao P; Cagle L; Hahn A; Conti DJ; Freed BM
    Transplantation; 2001 Feb; 71(4):577-80. PubMed ID: 11258441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A complementary strategy for pretransplant HLA antibody screening.
    Tiercy JM; Cattin S; Pongratz G; Goumaz C; Villard J
    Transplant Proc; 2002 May; 34(3):850-1. PubMed ID: 12034207
    [No Abstract]   [Full Text] [Related]  

  • 38. Sensitization to HLA by allografts is minimized by matching for HLA-A,B crossreactive groups.
    Lazda VA
    Transplant Proc; 2001; 33(1-2):393-4. PubMed ID: 11266878
    [No Abstract]   [Full Text] [Related]  

  • 39. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays--single-center experience.
    Mihaylova A; Baltadjieva D; Boneva P; Ivanova M; Penkova K; Marinova D; Mihailova S; Paskalev E; Simeonov P; Naumova E
    Hum Immunol; 2006 Oct; 67(10):787-94. PubMed ID: 17055355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.